Merger Love Triangle: Perrigo Rejects Mylan Again, Teva Pens Letter to Mylan Board
Source: Reuters
Apr 30, 2015
On Monday, Mylan rejected Teva's $40 billion offer and made public a scathing letter to Teva. Two days later, Perrigo rejected Mylan's latest offer, worth $34.1 billion.
Mylan claims Teva's offer grossly undervalues the company, and Mylan CEO Robert Coury expressed his extreme displeasure with the Israel-based company in a public letter. In response to Mylan's letter, Teva then sent its own letter to Mylan's board, reiterating that Teva’s proposal provides premium value for Mylan, and discouraging Mylan's "mudslinging."
Perrigo, which sells OTC consumer products, continues to assert that Mylan's latest offer is too low, and Mylan now plans take its offer for Perrigo directly to shareholders.
Read the Reuters updated press release
Join the discussion
We welcome your thoughtful comments.
All comments will display your user name.
Comments
No one has commented on this page yet.
RSS feed for comments on this page | RSS feed for all comments